A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC

Zuqin Rao1,2, Heng Li3, Wenchao Yao1,2

  • 1Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.

Frontiers in Oncology
|August 15, 2022
PubMed

Insights

Decaprenyl diphosphate synthase subunit 1 (PDSS1) is upregulated in hepatocellular carcinoma (HCC), correlating with poor prognosis and increased immune cell infiltration. PDSS1 knockdown inhibits HCC cell proliferation, migration, and invasion, suggesting it as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Decaprenyl diphosphate synthase subunit 1 (PDSS1) is implicated in human diseases, but its role in hepatocellular carcinoma (HCC) remains uncharacterized.
  • Understanding PDSS1's function in HCC is crucial for identifying novel biomarkers and therapeutic strategies.

Purpose of the Study:

  • To investigate the expression pattern, biological function, and prognostic significance of PDSS1 in HCC.
  • To explore the relationship between PDSS1 and immune infiltration in the HCC microenvironment.

Main Methods:

  • Analysis of PDSS1 expression using TCGA and GEO databases.
  • Correlation analysis of PDSS1 with clinicopathological characteristics and patient survival.
  • Gene Set Enrichment Analysis (GSEA) and assessment of immune cell infiltration using GSVA.
  • In vitro functional assays (EdU, colony formation, Transwell, wound healing, flow cytometry) to evaluate PDSS1's impact on HCC cell phenotype.
  • Investigation of PDSS1's role in oncogenic pathways, including STAT3 signaling.

Main Results:

  • PDSS1 was significantly upregulated in HCC tissues compared to adjacent non-tumorous tissues.
  • High PDSS1 expression correlated with unfavorable overall survival, disease-specific survival, and progression-free interval in HCC patients.
  • PDSS1 knockdown suppressed HCC cell proliferation, cell cycle progression, migration, and invasion, indicating its oncogenic role.
  • PDSS1 expression was associated with various immune cells, including Th2, TFH, T helper cells, NK cells, cytotoxic cells, dendritic cells, CD8 T cells, and neutrophils.
  • PDSS1 promotes tumorigenesis in HCC, potentially through the STAT3 signaling pathway.

Conclusions:

  • Elevated PDSS1 levels in HCC are linked to poor patient prognosis and altered immune cell infiltration.
  • PDSS1 functions as an oncogene in HCC, impacting cell proliferation, cycle, and invasion.
  • PDSS1 represents a promising novel biomarker and potential therapeutic target for hepatocellular carcinoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.8K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.4K